Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2032

Induced Pluripotent Stem Cell (iPSC) Market 2023 – By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types), By Application (Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy), By End-User (Hospitals, Research Laboratories), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $5000.00 $3350.00 | Pages : 310 | Published : May 2023 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

Induced Pluripotent Stem Cell (iPSC) Market Definition

Induced pluripotent stem cells (iPSC) are a type of artificial stem cells that are pluripotent, which can give rise to several different cell types, but are produced directly from somatic cells.

Induced pluripotent stem cell (iPSC) are derived from adult somatic cells such as fibroblasts or blood cells that have been reprogrammed into pluripotent stem cells by the introduction of a set of transcription factors linked to pluripotency. The resulting iPSCs can then be differentiated into a variety of cell types, such as cardiomyocytes, neuronal cells, hepatocytes and hematopoietic cells, using in vitro differentiation protocols.

These iPSC stem cells have broad applications in regenerative medicine, disease modeling, drug development and discovery, cell and gene therapy, and blood components synthesis. Importantly, because the iPSCs can be generated in a patient-specific manner, this technology can be used to develop autologous cell and regenerative therapies that can avoid immunologic rejection. They can also be used to generate patient/disease-specific models of different genetic disorders, to optimize patient-specific therapies, and to establish screens for drug testing and drug discovery.

Induced Pluripotent Stem Cell (iPSC) Market Size

The global induced pluripotent stem cell (iPSC) market reached a value of nearly $2,686.3 million in 2022, having increased at a compound annual growth rate (CAGR) of 10.7% since 2017. The market is expected to grow from $2,686.3 million in 2022 to $4,363.7 million in 2027 at a rate of 10.2%. The market is then expected to grow at a CAGR of 9.2% from 2027 and reach $6,763.4 million in 2032.  

Growth in the historic period resulted from increasing healthcare expenditure, a rise in funding, rising awareness of stem cell products' medicinal potential, use of induced pluripotent stem cell (iPSC) based drug discovery, increasing demand for personalized medicine and cost-effective benefits of iPSC for drug discovery. Factors that negatively affected growth in the historic period were a lack of awareness on induced pluripotent stem cell, high associated costs, technical limitations and lengthy process and inadequate reimbursements.

Going forward, an increasing prevalence of chronic diseases, growth in genomic projects, development of iPSC-derived disease models, an increasing prevalence of genetic diseases, government initiatives and a rapid increase in technology will drive the market. Factors that could hinder the growth of the induced pluripotent stem cell (iPSC) market in the future include automation of iPSC production, the risk associated with induced pluripotent stem cell treatment, disruption of medical facilities due to the Russia-Ukraine war and the coronavirus pandemic and high storage cost.

Induced Pluripotent Stem Cell (iPSC) Market Drivers

The key drivers of the induced pluripotent stem cell (iPSC) market include:

Increasing Prevalence Of Chronic Diseases

During the forecast period, the increasing prevalence of chronic diseases will support the growth of the induced pluripotent stem cell market. Chronic disorders such as diabetes, cancer, cancer, and stroke can be treated with induced pluripotent stem cells. Any tissue from a child or adult can be utilized to generate induced pluripotent stem cells, which have been genetically modified to behave like embryonic stem cells. For instance, in December 2022, according to Centers for Disease Control and Prevention, a US-based government agency, estimates that 6 out 10 adults in US have a chronic disease. Additionally, in January 2023, according to American Cancer Society (ACS) estimates, there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. Therefore, rise in incidences of chronic diseases is expected to drive the demand for induced pluripotent stem cell treatment in the forecast period.

Induced Pluripotent Stem Cell (iPSC) Market Restraints

The key restraints on the induced pluripotent stem cell (iPSC) market include:

Automation Of iPSC Production

Automation in the production of induced pluripotent stem cells (iPSC) is expected to inhibit the growth of the market. There is a deficiency in industrial processes for large scale production of human iPS cells for drug development. One reason is the high complexity of the manual processes involved and the need for highly qualified and experienced laboratory staff. Established biotechnological methods aim for a large scale production of one specific cell type. The iPS cell technology however demands the production, generation and differentiation of large numbers of individual iPS cell clones with the respective quality control. The transfer of manual laboratory processes for reprogramming, selection and expansion to an automatic production process requires innovative solutions when it comes to the system control unit. A major challenge is the systematic parallelization of all biotechnological production steps. Therefore, the adaptation of iPS cell production to industrial formats and automatic process steps for high throughput screening (HTS) has remained a major challenge, limiting market growth.

Induced Pluripotent Stem Cell (iPSC) Market Trends

Major trends influencing the induced pluripotent stem cell (iPSC) market include:

Development of Pluripotent Stem Cells For Parkinson’s Disease (PD)

Development of pluripotent stem cells for the treatment of Parkinson’s Disease (PD) is a key therapeutic objective in the induced pluripotent stem cell (iPSC) market. iPSCs can be used to generate dopaminergic neurons for transplantation or to model PD in the lab. Extensive research is being conducted on the use of induced pluripotent stem cells to treat Parkinson’s disease (PD). For instance, in April 2022, Aspen Neuroscience Inc., a US-based biotechnology company, launched first patient screening study for planned clinical trial of personalized cell replacement in Parkinson's disease. Further, in June 2022, BlueRock Therapeutics, a Germany-based, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, established expansion of the development of cell treatments in BlueRock's pipeline, with an initial focus on the ongoing BRT-DA01 clinical trial in Parkinson's disease. The creation of a BlueRock site in Berlin enhances the company's footprint and strengthens Bayer's cell therapy capabilities.

Strategic Collaborations And Partnerships

The trend of partnerships and collaborations is expected to continue, as companies look for new ways to create value and achieve growth. This trend is becoming increasingly popular, as companies seek to adapt to a rapidly changing business environment and stay competitive. The main objective of these partnerships is to combine resources, knowledge and expertise to achieve a mutual benefit, such as gaining access to new markets, technologies or customers, cost savings or risk reduction. Major companies operating in the induced pluripotent stem cell (iPSC) market are undertaking strategic initiatives such as collaborations and partnerships for product innovation to sustain in the increasingly competitive market. For instance, in November 2020, FUJIFILM Cellular Dynamics, Inc., a US-based developer and manufacturer of human-induced pluripotent stem cells (iPSCs) partnered with Lonza Walkersville, Inc., a US-based GMP iPSC manufacturer. Through this partnership, FUJIFILM Cellular Dynamics grants Lonza a non-exclusive licence to use its iPSC generation patents, and Lonza grants FUJIFILM Cellular Dynamics expanded use of its innovative Nucleofector technology. Through licencing agreements, the two companies combine their resources to create human induced pluripotent stem cells. Further, in September 2021, Bone Therapeutics, a Belgium-based bone cell therapy company, partnered with Implant Therapeutics, a US-based biotech company that engineers hypoimmunogenic iPSC-MSC cells containing panCELLa’s FailSafe and iACT Stealth Cell technologies. The collaboration will make Implant Therapeutics induced pluripotent stem cell (iPSC) lines, medium, differentiation techniques, and expertise available to Bone Therapeutics for access, evaluation, and material transfer.

Opportunities And Recommendations In The Induced Pluripotent Stem Cell (iPSC) Market

Opportunities –The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by derived cell type will arise in the fibroblasts market, which will gain $495.1 million of global annual sales by 2027. The top growth potential in the induced pluripotent stem cell (iPSC) market by application will arise in the drug discovery and toxicity studies market, which will gain $761.9 million of global annual sales by 2027. The top growth potential in the induced pluripotent stem cell (iPSC) market by end-users will arise in research laboratories market, which will gain $1,085.4 million of global annual sales by 2027. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $267.8 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the induced pluripotent stem cell (iPSC) companies to  focus on development of pluripotent stem cells for Parkinson’s disease (PD), focus on induced pluripotent stem cell iPSC-derived natural killer (NK) cells, focus on cell therapy, focus on iPSC expansion medium, focus on personalized iPSC, focus on pluripotent stem cells for type 1 diabetes, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, target fast-growing end-users, continue to target fast-growing applications and target the elderly population.

Induced Pluripotent Stem Cell (iPSC) Market Segmentation

The induced pluripotent stem cell (iPSC) market is segmented by derived cell type, by application and by end-user.
By Derived Cell Type -
The induced pluripotent stem cell (iPSC) market is segmented by derived cell type into:
    • a) Hepatocytes
    • b) Fibroblasts
    • c) Keratinocytes
    • d) Amniotic Cells
    • e) Other Derived Cell Types
The fibroblasts was the largest segment of the induced pluripotent stem cell (iPSC) market by derived cell type, accounting for $792.7 million or 29.5% of the total market in 2022. The other derived cell types market is expected to be the fastest-growing segment going forward at a CAGR of 10.7%.
By Application-
The induced pluripotent stem cell (iPSC) market is segmented by application into:
    • a) Academic Research
    • b) Drug Discovery And Toxicity Studies
    • c) Regenerative Medicine
    • d) Cell And Gene Therapy
The drug discovery and toxicity studies market was the largest segment of the induced pluripotent stem cell (iPSC) market by application, accounting for $1,294.8 million or 48.2% of the total market in 2022. The cell and gene therapy market is expected to be the fastest-growing segment going forward at a CAGR of 11.7%.
By End-User –
The induced pluripotent stem cell (iPSC) market is segmented by end-user into:
    • a) Hospitals
    • b) Research Laboratories
The research laboratories was the largest segment of the induced pluripotent stem cell (iPSC) market by end-users, accounting for $1,826.3 million or 86.0% of the total market in 2022. The hospitals market is expected to be the fastest-growing segment going forward at a CAGR of 11.0%.
By Geography - The induced pluripotent stem cell (iPSC) market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the induced pluripotent stem cell (iPSC) market, accounting for 47.7% of the global market in 2022. It was followed by Western Europe, Asia Pacific and the other regions. Going forward, the fastest growing regions in the induced pluripotent stem cell (iPSC) market will be South America and Middle East, where growth will be at CAGRs of 31.3% and 29.6%respectively from 2022-2027.

Induced Pluripotent Stem Cell (iPSC) Market Competitive Landscape

Major Competitors are:

  • FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc)
  • Thermo Fisher Scientific, Inc
  • Takara Bio, Inc
  • Lonza Group AG
  • Astellas Pharma Inc
  • Other Competitors Include:

  • ViaCyte, Inc
  • Ncardia
  • REPROCELL USA, Inc
  • Japan Tissue Engineering Co., Ltd
  • Merck KGaA
  • Cynata Therapeutics Limited
  • Dainippon Sumitomo Pharma
  • Shenzhen Bioscience
  • Shanghai Cell Therapy Group
  • Car-T Bio
  • JW therapeutics
  • Fosun Kite Biotechnology
  • Shanghai UniCar Therapy
  • Takaria Bio
  • REPROCELL
  • SEED Biosciences SA
  • Cellerix
  • CellGenix
  • NsGene
  • TiGenix
  • Renuron Group
  • Smart Cells
  • Genenta Science
  • Biocad Rf
  • MSD
  • Pfizer
  • Roche
  • Pharmasyntez
  • Selvita
  • Mabion
  • Pure Biologics
  • OncoArendi Therapeutics
  • Proteon Pharmaceuticals
  • GlaxoSmithKline
  • Parexel
  • Bayer
  • Thermo Fisher Scientific
  • Fate Therapeutics
  • ViaCyteSangamo Therapeutics
  • Athersys
  • BrainStorm Cell Therapeutics
  • Cellular Biomedicine Group
  • Pluristem Therapeutics
  • Gamida Cell
  • VistaGen Therapeutics
  • Caladrius Biosciences
  • ThermoGenesis Holdings
  • BioCanRx
  • CellCAN
  • CCRM
  • C3i
  • BioCells Argentina
  • Banco de Cordon del Peru
  • CryoHoldco
  • CellSave Arabia
  • Life Cell
  • AmiCare
  • Cells4life
  • ReeLabs
  • Stem Cells
  • Royan Stem Cell Technology Co.
  • Next BioSciences
  • CryoSave
  • BioHeart
  • Stem Cell Technologies
  • Net Cells
    1. Table Of Contents

      1. Executive Summary

      2. Table Of Contents

      3. List Of Figures

      4. List Of Tables

      5. Report Structure

      6. Introduction And Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Induced Pluripotent Stem Cell (iPSC) Market Definition And Segmentations

      6.4. Market Segmentation By Derived Cell Type

      6.4.1. Blood Cells

      6.4.2. Hepatocytes

      6.4.3. Fibroblasts

      6.4.4. Keratinocytes

      6.4.5. Amniotic Cells

      6.4.6. Other Derived Cell Types

      6.5. Market Segmentation By Application

      6.5.1. Academic Research

      6.5.2. Drug Discovery And Toxicity Studies

      6.5.3. Regenerative Medicine

      6.5.4. Cell And Gene Therapy

      6.6. Market Segmentation By End-User

      6.6.1. Hospitals

      6.6.2. Research Laboratories

      7. Major Market Trends

      7.1. Development of Pluripotent Stem Cells For Parkinson’s Disease (PD)

      7.2. Strategic Collaborations And Partnerships

      7.3. Induced Pluripotent Stem Cell iPSC-Derived NK Cells

      7.4. Induced Pluripotent Stem Cell (iPSC) For Cell Therapy

      7.5. Investment In Regenerative Medicine Research And Development

      7.6. Development of iPSC Expansion Medium

      7.7. Personalized iPSC

      7.8. Pluripotent Stem Cells For Type I Diabetes

      8. Global Market Size and Growth

      8.1. Market Size

      8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

      8.2.1. Market Drivers 2017 – 2022

      8.2.2. Market Restraints 2017 – 2022

      8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      8.3.1. Market Drivers 2022 – 2027

      8.3.2. Market Restraints 2022 – 2027

      9. Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation

      9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10. Induced Pluripotent Stem Cell (iPSC) Market, Regional and Country Analysis

      10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11. Asia-Pacific Market

      11.1. Summary

      11.2. Market Overview

      11.2.1. Region Information

      11.2.2. Market Information

      11.2.3. Background Information

      11.2.4. Government Initiatives

      11.2.5. Regulations

      11.2.6. Regulatory Bodies

      11.2.7. Major Associations

      11.2.8. Taxes levied

      11.2.9. Corporate Tax Structure

      11.2.10. Investments

      11.2.11. Major Companies

      11.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.7. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.8. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      11.9. China Market

      11.10. Summary

      11.11. Market Overview

      11.11.1. Country Information

      11.11.2. Market Information

      11.11.3. Background Information

      11.11.4. Government Initiatives

      11.11.5. Regulations

      11.11.6. Regulatory Bodies

      11.11.7. Major Associations

      11.11.8. Taxes levied

      11.11.9. Corporate tax structure

      11.11.10. Investments

      11.11.11. Major Companies

      11.12. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.13. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.14. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.15. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.16. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.17. India Market

      11.18. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.19. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.20. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.21. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.22. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.23. Japan Market

      11.24. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.25. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.26. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.27. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.28. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.29. Australia Market

      11.30. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.31. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.32. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.33. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.34. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.35. Indonesia Market

      11.36. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.37. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.38. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.39. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.40. South Korea Market

      11.41. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      11.42. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      11.43. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.44. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.45. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12. Western Europe Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory Bodies

      12.2.7. Major Associations

      12.2.8. Taxes levied

      12.2.9. Corporate tax structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.7. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.8. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      12.9. UK Market

      12.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.12. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.13. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.14. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.15. Germany Market

      12.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.17. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.18. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.19. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.20. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.21. France Market

      12.22. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.23. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.24. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.25. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.26. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13. Eastern Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.7. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.8. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      13.9. Russia Market

      13.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.12. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.13. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.14. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14. North America Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.6. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.7. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.8. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      14.9. USA Market

      14.10. Summary

      14.11. Market Overview

      14.11.1. Country Information

      14.11.2. Market Information

      14.11.3. Background Information

      14.11.4. Government Initiatives

      14.11.5. Regulations

      14.11.6. Regulatory Bodies

      14.11.7. Major Associations

      14.11.8. Taxes Levied

      14.11.9. Corporate Tax Structure

      14.11.10. Investments

      14.11.11. Major Companies

      14.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.13. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.14. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.15. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.16. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15. South America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.6. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.7. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.8. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      15.9. Brazil Market

      15.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.12. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.13. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.14. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16. Middle East Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory bodies

      16.2.7. Taxes Levied

      16.2.8. Corporate Tax Structure

      16.2.9. Major Associations

      16.2.10. Investments

      16.2.11. Major Companies

      16.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      16.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      16.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.6. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.7. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17. Africa Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background Information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      17.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.5. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.6. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18. Competitive Landscape and Company Profiles

      18.1. Company Profiles

      18.2. FUJIFILM Holdings Corporation

      18.2.1. Company Overview

      18.2.2. Products And Services

      18.2.3. Business Strategy

      18.2.4. Financial Overview

      18.3. Thermo Fisher Scientific, Inc

      18.3.1. Company Overview

      18.3.2. Products And Services

      18.3.3. Business Strategy

      18.3.4. Financial Overview

      18.4. Takara Bio, Inc

      18.4.1. Company Overview

      18.4.2. Products And Services

      18.4.3. Business Strategy

      18.4.4. Financial Overview

      18.5. Lonza Group AG

      18.5.1. Company Overview

      18.5.2. Products And Services

      18.5.3. Business Strategy

      18.5.4. Financial Overview

      18.6. Astellas Pharma Inc

      18.6.1. Company Overview

      18.6.2. Products And Services

      18.6.3. Business Strategy

      18.6.4. Financial Overview

      19. Key Mergers and Acquisitions

      19.1. Century Therapeutics Collaborated With Bristol Myers Squibb

      19.2. CellOrigin Biotech Collaborated With Qilu Pharmaceutical

      19.3. Evotec Acquired Rigenerand

      19.4. Vertex Pharmaceuticals Acquired ViaCyte

      19.5. Medipost Acquired OmniaBio

      19.6. Catalent Acquired RheinCell Therapeutics

      20. Opportunities And Strategies

      20.1. Global Induced Pluripotent Stem Cell (iPSC) Market In 2027 – Countries Offering Most New Opportunities

      20.2. Global Induced Pluripotent Stem Cell (iPSC) Market In 2027 – Segments Offering Most New Opportunities

      20.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2027 – Growth Strategies

      20.3.1. Market Trend Based Strategies

      20.3.2. Competitor Strategies

      21. Induced Pluripotent Stem Cell (iPSC) Market, Conclusions And Recommendations

      21.1. Conclusions

      21.2. Recommendations

      21.2.1. Product

      21.2.2. Place

      21.2.3. Price

      21.2.4. Promotion

      21.2.5. People

      22. Appendix

      22.1. Market Data Sources

      22.2. Research Methodology

      22.3. Currencies

      22.4. The Business Research Company

      22.5. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 2: Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 3: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 4: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 9: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 10: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 11: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 12: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 13: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $
    • Table 14:  Asia-Pacific Population, By Country, 2017-2027, Millions
    • Table 15: Asia-Pacific, Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 16: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 17: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 18: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 19: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 20: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 21: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 22: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 23: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 24: China GDP Per Capita, 2017-2022, $
    • Table 25:  China Population, By Country, 2017-2027, Millions
    • Table 26: China Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 27: China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 28: China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 29: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 30: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 31: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 32: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 33: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 34: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 35: India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 36: India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 37: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 38: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 39: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 40: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 41: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 42: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 43: Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 44: Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 45: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 46: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 47: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 48: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 49: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 50: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 51: Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 52: Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 53: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 54: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 55: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 56: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 57: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 58: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 59: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 60: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 61: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 62: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 63: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 64: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 65: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 66: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 67: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 68: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 69: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 70: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 71: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 72: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 73: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 74: Western Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 75:  Western Europe Population, By Country, 2017-2027, Millions
    • Table 76: Western Europe Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 77: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 78: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 79: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 80: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 81: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 82: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 83: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 84: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 85: UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 86: UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 87: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 88: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 89: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 90: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 91: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 92: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 93: Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 94: Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 95: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 96: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 97: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 98: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 99: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 100: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 101: France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 102: France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 103: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 104: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 105: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 106: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 107: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 108: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 109: Eastern Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 110:  Eastern Europe Population, By Country, 2017-2027, Millions
    • Table 111: Eastern Europe Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 112: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 113: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 114: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 115: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 116: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 117: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 118: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 119: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 120: Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 121: Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 122: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 123: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 124: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 125: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 126: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 127: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 128: North America GDP Per Capita, By Country, 2017-2022, $
    • Table 129:  North America Population, By Country, 2017-2027, Millions
    • Table 130: North America Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 131: North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 132: North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 133: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 134: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 135: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 136: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 137: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 138: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 139: USA GDP Per Capita, 2017-2022, $
    • Table 140:  USA Population, By Country, 2017-2027, Millions
    • Table 141: USA Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 142: USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 143: USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 144: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 145: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 146: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 147: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 148: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 149: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 150: South America GDP Per Capita, By Country, 2017-2022, $
    • Table 151:  South America Population, By Country, 2017-2027, Millions
    • Table 152: South America Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 153: South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 154: South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 155: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 156: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 157: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 158: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 159: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 160: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 161: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 162: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 163: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 164: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 165: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 166: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 167: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 168: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 169: Middle East GDP Per Capita, By Country, 2017-2022, $
    • Table 170:  Middle East Population, By Country, 2017-2027, Millions
    • Table 171: Middle East Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 172: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Table 173: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 174: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 175: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 176: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 177: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 178: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 179: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 180: Africa GDP Per Capita, By Country, 2017-2022, $
    • Table 181:  Africa Population, By Country, 2017-2027, Millions
    • Table 182: Africa Healthcare Services Market Size, By Country, 2017-2027, $ Billion
    • Table 183: Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 184: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 185: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 186: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 187: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 188: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 189: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 190: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 191: Fujifilm Holding’s – Financial Performance, 2017– 2021, $ Billion
    • Table 192: Thermo Fisher – Financial Performance, 2017-2021, $ Billion
    • Table 193: Takara Bio – Financial Performance, 2017– 2021, $ Billion
    • Table 194: Lonza – Financial Performance, 2017 – 2021, $ Billion
    • Table 195: Astellas – Financial Performance, 2017– 2021, $ Billion
    • Table 196: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), 2022 – 2027, By Country
    • Table 197: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By Derived Cell Type, 2022 – 2027
    • Table 198: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By End-User, 2022 – 2027
    • Table 199: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Million), Segmentation By Application, 2022 – 2027
    • Table 200: Induced Pluripotent Stem Cell (iPSC) - Market Data Sources

    List Of Figures

      Figure 1: Geographic Regions Covered
    • Figure 2: Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation By Derived Cell Type
    • Figure 3: Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation By Application
    • Figure 4: Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation By End-User
    • Figure 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 9: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 10: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 11: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 12: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 13: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 14: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 15: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 16: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 17: China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 18: China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 19: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 20: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 21: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 22: India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 23: India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 24: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 25: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 26: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 27: Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 28: Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 29: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 30: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 31: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 32: Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 33: Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 34: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 35: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 36: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 37: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 38: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 39: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 40: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 41: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 42: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 43: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 44: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 45: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 46: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 47: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 48: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 49: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 50: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 51: UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 52: UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 53: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 54: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 55: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 56: Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 57: Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 58: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 59: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 60: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 61: France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 62: France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 63: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 64: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 65: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 66: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 67: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 68: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 69: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 70: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 71: Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 72: Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 73: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 74: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 75: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 76: North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 77: North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 78: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 79: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 80: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 81: USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 82: USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 83: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 84: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 85: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 86: South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 87: South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 88: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 89: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 90: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 91: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 92: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 93: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 94: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 95: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 96: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2017 – 2022, $ Million
    • Figure 97: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 98: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 99: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 100: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 101: Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 102: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 103: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 104: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 105: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Figure 106: Fujifilm Holding’s – Financial Performance, 2017– 2021, $ Billion
    • Figure 107: Thermo Fisher – Financial Performance, 2017-2021, $ Billion
    • Figure 108: Takara Bio – Financial Performance, 2017– 2021, $ Billion
    • Figure 109: Lonza – Financial Performance, 2017 – 2021, $ Billion
    • Figure 110: Astellas – Financial Performance, 2017– 2021, $ Billion
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report